PPLPHARMA Piramal Pharma Limited NSE · India

Piramal Pharma (PPLPHARMA) news

Piramal Pharma Limited is a public biotech or pharmaceutical company listed on NSE under the ticker PPLPHARMA, recorded under India. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Piramal Pharma news

We have not published a story on Piramal Pharma yet. When there is news, it will appear here.

Questions about Piramal Pharma

What is the ticker symbol of Piramal Pharma?

Piramal Pharma Limited trades under the ticker PPLPHARMA on NSE.

Where is Piramal Pharma listed?

Piramal Pharma Limited is listed on NSE. Our directory also records these other listings: BSE:PPLPHARMA.

Which country or territory is Piramal Pharma listed under?

Our directory records Piramal Pharma Limited under India.

What does Piramal Pharma do?

Our directory classifies Piramal Pharma Limited as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Piramal Pharma?

The ISIN recorded for Piramal Pharma Limited is INE0DK501011.

Does aibio.space cover Piramal Pharma?

aibio.space lists Piramal Pharma Limited among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Piramal Pharma?

Companies in our directory listed in the same country and business area as Piramal Pharma: Suven Life Sciences, Lasa Supergenerics, Vilin Bio Med, Bafna Pharmaceuticals, Remus Pharmaceuticals, Bliss GVS Pharma.

Investor discussion: Piramal Pharma

Members talk about Piramal Pharma (PPLPHARMA). Reader posts, not aibio.space reporting, and not investment advice.

Rules

Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Press releases

Headlines of Piramal Pharma's own announcements, newest first. Each opens the full release on the newswire that carried it.

Oct 29, 2026PR Newswire
Piramal Pharma Limited annonce ses résultats pour le deuxième trimestre et le premier semestre de l'exercice 2027
Oct 28, 2026PR Newswire
Piramal Pharma Limited gibt Ergebnisse für das 2. Quartal und das 1. Halbjahr des Geschäftsjahres 2027 bekannt
Oct 27, 2026PR Newswire
Piramal Pharma Limited Announces Results for Q2 and H1 FY27

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open NSE:PPLPHARMA on TradingView.

Listing details

Company: Piramal Pharma Limited
Ticker: PPLPHARMA
Listing: NSE
Country or territory: India
Business scope: Pharmaceuticals: Major
ISIN: INE0DK501011
Other listed symbols: BSE:PPLPHARMA
Last quote in directory: 2026-10-22
Directory source: Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction